Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6054718 | 0.93 | ADRB2 (0.43) | ADRB2ADRB1TSHRALOX15LMNA | |
| SCHEMBL7249592 | 0.88 | KMT2A (0.42) | ADRB2ADRB1TSHRALOX15LMNA | |
| SCHEMBL5042442 | 0.88 | PTPN1 (0.44) | ADRB2ADRB1ALOX15LMNAMAPK1 | |
| SCHEMBL30564892 | 0.87 | ABCB1 (0.39) | ADRB2ADRB1LMNAGAAMAPK1 | |
| SCHEMBL6397184 | 0.87 | ABCB1 (0.39) | ADRB2ADRB1LMNAGAAMAPK1 | |
| SCHEMBL27838229 | 0.87 | ADRB2 (0.59) | ADRB2ADRB1TSHRLMNAMEN1 | |
| SCHEMBL1098212 | 0.83 | MAPT (0.51) | TSHRLMNAGAAMAPK1MEN1 | |
| SCHEMBL12755315 | 0.81 | LMNA (0.42) | ADRB2ADRB1TSHRALOX15LMNA | |
| SCHEMBL6051267 | 0.80 | ADRB2 (0.44) | ADRB2ADRB1TSHRALOX15MEN1 | |
| SCHEMBL27965176 | 0.80 | ADRB2 (0.48) | ADRB2ADRB1TSHRALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1989 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240084104-A1 | ADDITIVE MIXTURES | BASF SE (DE) | 2024-03-14 | — | — | US | claimed |
| US-9543521-B2 | Organic semiconductor device and process for its production | BASF SE (DE) | 2017-01-10 | — | — | US | claimed |
| US-20140306212-A1 | ORGANIC SEMICONDUCTOR DEVICE AND PROCESS FOR ITS PRODUCTION | BASF SE (DE) | 2014-10-16 | — | — | US | claimed |
| EP-2780409-A1 | ORGANIC SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF | BASF SE (DE) | 2014-09-24 | — | — | EP | claimed |
| US-20130306151-A1 | ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF | BASF SE (DE) | 2013-11-21 | — | — | US | claimed |
| EP-2663595-A1 | ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF | BASF SE (DE) | 2013-11-20 | — | — | EP | claimed |
| WO-2013072853-A1 | ORGANIC SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF | BASF SE (DE) | 2013-05-23 | — | — | WO | claimed |
| WO-2012095796-A1 | ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF | BASF SE (DE) | 2012-07-19 | — | — | WO | claimed |
| EP-1310492-B1 | Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers | CYTEC TECH CORP (US) | 2012-01-11 | — | — | EP | claimed |
| EP-1814937-B1 | ANTIMICROBIAL POLYMER COMPOSITIONS HAVING IMPROVED DISCOLORATION RESISTANCE | CIBA HOLDING INC (CH) | 2009-07-29 | — | — | EP | claimed |
| WO-2003057772-A2 | UV STABILIZED THERMOPLASTIC OLEFINS | CYTEC TECHNOLOGY CORP. (US) | 2003-07-17 | — | — | WO | claimed |
| EP-1310492-A1 | Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers | CYTEC TECHNOLOGY CORP. (US) | 2003-05-14 | — | — | EP | claimed |
| US-20030088098-A1 | Novel red-shifted triazine ultravioletlight absorbers | CYTEC TECHNOLOGY CORP. | 2003-05-08 | — | — | US | claimed |
| WO-2003035733-A1 | PROCESS FOR IMPROVING THE SHELF LIFE OF A HINDERED PHENOL ANTIOXIDANT | CYTEC TECHNOLOGY CORP. (US) | 2003-05-01 | — | — | WO | claimed |
| US-20030073771-A1 | Process for improving the shelf life of a hindered phenol antioxidant | CYTEC TECHNOLOGY CORP. | 2003-04-17 | — | — | US | claimed |
| EP-1298126-A1 | Novel red-shifted triazine ultraviolet light absorbers | CYTEC TECHNOLOGY CORP. (US) | 2003-04-02 | — | — | EP | claimed |
| US-20020161075-A1 | Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds | CYTEC TECHNOLOGY CORP. | 2002-10-31 | — | — | US | claimed |
| WO-2002036579-A1 | NON-YELLOWING ORTHO-DIALKYL ARYL SUBSTITUTED TRIAZINE ULTRAVIOLET LIGHT ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 2002-05-10 | — | — | WO | claimed |
| US-6384113-B1 | POLYMER STABILIZER; LOW VOLATILITY; WEATHERABILITY; YELLOWING RESISTANCE | CYTEC TECHNOLOGY CORP. | 2002-05-07 | — | — | US | claimed |
| US-20020028937-A1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC TECHNOLOGY CORP. | 2002-03-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030088098-A1 | Novel red-shifted triazine ultravioletlight absorbers | SUN2, RAD52, XPO5 | ADRB2 1403/4885ADRB1 1173/4885TSHR 1929/4885 |
| US-20020028937-A1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | ERCC5, ERCC4, ERCC2 | ADRB2 1505/4885ADRB1 1897/4885TSHR 1732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.